Plasticity and remodeling of brain

Journal of the Neurological Sciences

Volumn 265, Issue 1-2, 2008, Pages 97-101

  Chopp, Michael ^a,b   Li, Yi ^a   Zhang, Jing ^a  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Bone marrow mesenchymal cells; Brain plasticity; EAE; Erythropoietin; Neurorestorative therapy; Recovery; Stroke; White matter

Indexed keywords

ERYTHROPOIETIN;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; BONE MARROW CELL; BRAIN INJURY; CELL THERAPY; MESENCHYME CELL; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICE; NEURONAL PLASTICITY;

EID: 37849028382     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.06.013     Document Type: Article

References (93)

1. Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab 20 (2000) 1393-1408
2. Kawamata T., Dietrich W.D., Schallert T., Gotts J.E., Cocke R.R., Benowitz L.I., et al. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci U S A 94 (1997) 8179-8184
3. Savitz S.I., Rosenbaum D.M., Dinsmore J.H., Wechsler L.R., and Caplan L.R. Cell transplantation for stroke. Ann Neurol 52 (2002) 266-275
4. Mergenthaler P., Dirnagl U., and Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 19 (2004) 151-167
5. Fujimoto S.T., Longhi L., Saatman K.E., Conte V., Stocchetti N., and McIntosh T.K. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci Biobehav Rev 28 (2004) 365-378
6. Morganti-Kossmann M.C., Rancan M., Otto V.I., Stahel P.F., and Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 16 (2001) 165-177
7. Cramer S.C., and Chopp M. Recovery recapitulates ontogeny. Trends Neurosci 23 (2000) 265-271
8. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell Biol 7 (1995) 148-155
9. Li Y., and Chopp M. Temporal profile of nestin expression after focal cerebral ischemia in adult rat. Brain Res 838 (1999) 1-10
10. Sahin Kaya S., Mahmood A., Li Y., Yavuz E., and Chopp M. Expression of nestin after traumatic brain injury in rat brain. Brain Res 840 (1999) 153-157
11. Duggal N., Schmidt-Kastner R., and Hakim A.M. Nestin expression in reactive astrocytes following focal cerebral ischemia in rats. Brain Res 768 (1997) 1-9
12. Li Y., Chopp M., Powers C., and Jiang N. Immunoreactivity of cyclin d1/cdk4 in neurons and oligodendrocytes after focal cerebral ischemia in rat. J Cereb Blood Flow Metab 17 (1997) 846-856
13. Zhang R., Zhang Z., Tsang W., Wang L., and Chopp M. Down-regulation of p27kip1 increases proliferation of progenitor cells in adult rats. Neuroreport 15 (2004) 1797-1800
14. Doetsch F., Verdugo J.M., Caille I., Alvarez-Buylla A., Chao M.V., and Casaccia-Bonnefil P. Lack of the cell-cycle inhibitor p27kip1 results in selective increase of transit-amplifying cells for adult neurogenesis. J Neurosci 22 (2002) 2255-2264
15. Albensi B.C. Models of brain injury and alterations in synaptic plasticity. J Neurosci Res 65 (2001) 279-283
16. Brown J.A. Chapter 15 recovery of motor function after stroke. Prog Brain Res 157 (2006) 223-228
17. Fraser C., Power M., Hamdy S., Rothwell J., Hobday D., Hollander I., et al. Driving plasticity in human adult motor cortex is associated with improved motor function after brain injury. Neuron 34 (2002) 831-840
18. Lu D., Mahmood A., Wang L., Li Y., Lu M., and Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 12 (2001) 559-563
19. Mahmood A., Lu D., Qu C., Goussev A., and Chopp M. Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J Neurosurg 104 (2006) 272-277
20. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
21. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49 (2005) 407-417
22. Chen J., and Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 3 (2006) 466-473
23. Chen J., Zhang C., Jiang H., Li Y., Zhang L., Robin A., et al. Atorvastatin induction of vegf and bdnf promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 25 (2005) 281-290
24. Zhang L., Zhang Z., Zhang R.L., Cui Y., Lapointe M.C., Silver B., et al. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res 1118 1 (2006) 192-198
25. Zhang R., Wang L., Zhang L., Chen J., Zhu Z., Zhang Z., et al. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cgmp after stroke in the rat. Circ Res 92 (2003) 308-313
26. Zhang L., Zhang Z.G., Ding G.L., Jiang Q., Liu X., Meng H., et al. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation 112 (2005) 3486-3494
27. Zhang R.L., Zhang Z.G., and Chopp M. Increased therapeutic efficacy with rt-pa and anti-cd18 antibody treatment of stroke in the rat. Neurology 52 (1999) 273-279
28. Zhang Z., and Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 12 (2002) 62-66
29. Li Y., McIntosh K., Chen J., Zhang C., Gao Q., Borneman J., et al. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats. Exp Neurol 198 (2006) 313-325
30. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32 (2001) 2682-2688
31. Lu D., Sanberg P.R., Mahmood A., Li Y., Wang L., Sanchez-Ramos J., et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11 (2002) 275-281
32. Lu D., Li Y., Mahmood A., Wang L., Rafiq T., and Chopp M. Neural and marrow-derived stromal cell sphere transplantation in a rat model of traumatic brain injury. J Neurosurg 97 (2002) 935-940
33. Li Y., Yang X., Chen J., Wang L., Wang Y., Zhang C., et al. Transplantation of a new composite of fetal neural tissue and adult bone marrow stromal cells into the rat brain after stroke. Neurosci Res Commun 30 (2002) 155-163
34. Zhang Z., Jiang Q., Jiang F., Ding G., Zhang R., Wang L., et al. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 23 (2004) 281-287
35. Chen J., Zacharek A., Li Y., Li A., Wang L., Katakowski M., et al. N-cadherin mediates nitric oxide-induced neurogenesis in young and retired breeder neurospheres. Neuroscience 140 (2006) 377-388
36. Liu X.S., Zhang Z.G., Zhang L., Morris D.C., Kapke A., Lu M., et al. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. J Cereb Blood Flow Metab 26 (2006) 787-796
37. Ding G., Jiang Q., Li L., Zhang L., Zhang Z.G., Panda S., et al. Mri of combination treatment of embolic stroke in rat with rtpa and atorvastatin. J Neurol Sci 246 (2006) 139-147
38. Wang L., Zhang Z., Wang Y., Zhang R., and Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
39. Lu D., Mahmood A., Qu C., Goussev A., Schallert T., and Chopp M. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 22 (2005) 1011-1017
40. Zhang R.L., Zhang Z., Zhang L., Wang Y., Zhang C., and Chopp M. Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res 83 (2006) 1213-1219
41. Meng H., Zhang Z., Zhang R., Liu X., Wang L., Robin A.M., et al. Biphasic effects of exogenous vegf on vegf expression of adult neural progenitors. Neurosci Lett 393 (2006) 97-101
42. Jiang Q., Zhang Z.G., Ding G.L., Zhang L., Ewing J.R., Wang L., et al. Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using mri. Neuroimage 28 (2005) 698-707
43. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53 (2003) 743-751
44. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92 (2003) 692-699
45. Zhang C., Li Y., Chen J., Gao Q., Zacharek A., Kapke A., et al. Bone marrow stromal cells upregulate expression of bone morphogenetic proteins 2 and 4, gap junction protein connexin-43 and synaptophysin after stroke in rats. Neuroscience 141 (2006) 687-695
46. Shen L.H., Li Y., Chen J., Zhang J., Vanguri P., Borneman J., et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 137 (2006) 393-399
47. Jiang Q., Zhang Z.G., Ding G.L., Silver B., Zhang L., Meng H., et al. Mri detects white matter reorganization after neural progenitor cell treatment of stroke. Neuroimage 32 (2006) 1080-1089
48. Zhang J., Li Y., Cui Y., Chen J., Lu M., Elias S.B., et al. Erythropoietin treatment improves neurological functional recovery in eae mice. Brain Res 1034 (2005) 34-39
49. Zhang J., Li Y., Lu M., Cui Y., Chen J., Noffsinger L., et al. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 84 (2006) 587-595
50. Zhang J., Li Y., Chen J., Cui Y., Lu M., Elias S.B., et al. Human bone marrow stromal cell treatment improves neurological functional recovery in eae mice. Exp Neurol 195 (2005) 16-26
51. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59 (2002) 514-523
52. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 11 (2005) 400-407
53. Chen X., Li Y., Wang L., Katakowski M., Zhang L., Chen J., et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22 (2002) 275-279
54. Mahmood A., Lu D., and Chopp M. Intravenous administration of marrow stromal cells (mscs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 21 (2004) 33-39
55. Xin H., Li Y., Chen X., and Chopp M. Bone marrow stromal cells induce bmp2/4 production in oxygen-glucose-deprived astrocytes, which promotes an astrocytic phenotype in adult subventricular progenitor cells. J Neurosci Res 83 (2006) 1485-1493
56. Chopp M., and Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 1 (2002) 92-100
57. Shen L.H., Li Y., Chen J., Zacharek A., Gao Q., Kapke A., et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 27 1 (2006) 6-13
58. Kozak T., Havrdova E., Pitha J., Gregora E., Pytlik R., Maaloufova J., et al. Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis. Cas Lek Cesk 139 (2000) 263-266
59. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422 (2003) 688-694
60. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing t-cell anergy. Blood 106 (2005) 1755-1761
61. Devine S.M., Peter S., Martin B.J., Barry F., and McIntosh K.R. Mesenchymal stem cells: stealth and suppression. Cancer J 7 Suppl 2 (2001) S76-S82
62. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102 (2003) 3837-3844
63. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., and Guinan E.C. Suppression of allogeneic t-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389-397
64. Chopp M., and Li Y. Functional recovery after stroke with cell-based therapy. Acute Stroke: Bench to Bedside (2006) 473-480
65. Chen J., Li Y., Katakowski M., Chen X., Wang L., Lu D., et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73 (2003) 778-786
66. Hiwatashi A., Zhong J., Ekholm S.E., and Westesson P.L. Fractional anisotropy is higher in Heschl's gyrus than in superior temporal gyrus in normal subjects. Acad Radiol 13 (2006) 73-76
67. Dubois J., Hertz-Pannier L., Dehaene-Lambertz G., Cointepas Y., and Le Bihan D. Assessment of the early organization and maturation of infants' cerebral white matter fiber bundles: a feasibility study using quantitative diffusion tensor imaging and tractography. Neuroimage 30 (2006) 1121-1132
68. Berman J.I., Berger M.S., Mukherjee P., and Henry R.G. Diffusion-tensor imaging-guided tracking of fibers of the pyramidal tract combined with intraoperative cortical stimulation mapping in patients with gliomas. J Neurosurg 101 (2004) 66-72
69. Lori N.F., Akbudak E., Shimony J.S., Cull T.S., Snyder A.Z., Guillory R.K., et al. Diffusion tensor fiber tracking of human brain connectivity: acquisition methods, reliability analysis and biological results. NMR Biomed 15 (2002) 494-515
70. Goldberg-Zimring D., and Warfield S.K. Novel image processing techniques to better understand white matter disruption in multiple sclerosis. Autoimmun Rev 5 (2006) 544-548
71. Duncan J.S., Papademetris X., Yang J., Jackowski M., Zeng X., and Staib L.H. Geometric strategies for neuroanatomic analysis from mri. Neuroimage 23 Suppl 1 (2004) S34-S45
72. Westin C.F., Maier S.E., Mamata H., Nabavi A., Jolesz F.A., and Kikinis R. Processing and visualization for diffusion tensor mri. Med Image Anal 6 (2002) 93-108
73. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13 (2001) 534-546
74. Cohen Y., and Assaf Y. High b-value q-space analyzed diffusion-weighted mrs and mri in neuronal tissues - a technical review. NMR Biomed 15 (2002) 516-542
75. Assaf Y., Ben-Bashat D., Chapman J., Peled S., Biton I.E., Kafri M., et al. High b-value q-space analyzed diffusion-weighted mri: application to multiple sclerosis. Magn Reson Med 47 (2002) 115-126
76. Lu H., Jensen J.H., Ramani A., and Helpern J.A. Three-dimensional characterization of non-gaussian water diffusion in humans using diffusion kurtosis imaging. NMR Biomed 19 (2006) 236-247
77. Jensen J.H., Helpern J.A., Ramani A., Lu H., and Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 53 (2005) 1432-1440
78. Goldberg-Zimring D., Mewes A.U., Maddah M., and Warfield S.K. Diffusion tensor magnetic resonance imaging in multiple sclerosis. J Neuroimaging 15 (2005) 68S-81S
79. Wang L., Zhang Z., Zhang R., Hafner M.S., Wong H.K., Jiao Z., et al. Erythropoietin up-regulates socs2 in neuronal progenitor cells derived from svz of adult rat. Neuroreport 15 (2004) 1225-1229
80. Hasselblatt M., Ehrenreich H., and Siren A.L. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol 18 (2006) 132-138
81. Lewis L.D. Preclinical and clinical studies: a preview of potential future applications of erythropoietic agents. Semin Hematol 41 (2004) 17-25
82. Ehrenreich H., Aust C., Krampe H., Jahn H., Jacob S., Herrmann M., et al. Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis 19 (2004) 195-206
83. Coleman T., and Brines M. Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?. Crit Care 8 (2004) 337-341
84. Milano M., and Collomp R. Erythropoietin and neuroprotection: a therapeutic perspective. J Oncol Pharm Pract 11 (2005) 145-149
85. Tsai P.T., Ohab J.J., Kertesz N., Groszer M., Matter C., Gao J., et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26 (2006) 1269-1274
86. Chen Z.Y., Warin R., and Noguchi C.T. Erythropoietin and normal brain development: receptor expression determines multi-tissue response. Neurodegener Dis 3 (2006) 68-75
87. Buemi M., Cavallaro E., Floccari F., Sturiale A., Aloisi C., Trimarchi M., et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin Sci (Lond) 103 (2002) 275-282
88. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M.L., et al. Erythropoietin exerts an anti-inflammatory effect on the cns in a model of experimental autoimmune encephalomyelitis. Brain Res 952 (2002) 128-134
89. Gaston K.E., Kouba E., Moore D.T., and Pruthi R.S. The use of erythropoietin in patients undergoing radical prostatectomy: effects on hematocrit, transfusion rates and quality of life. Urol Int 77 (2006) 211-215
90. Raine A.E., and Roger S.D. Effects of erythropoietin on blood pressure. Am J Kidney Dis 18 (1991) 76-83
91. Erbayraktar S., de Lanerolle N., de Lotbiniere A., Knisely J.P., Erbayraktar Z., Yilmaz O., et al. Carbamylated erythropoietin reduces radiosurgically-induced brain injury. Mol Med 12 (2006) 74-80
92. Villa P., van Beek J., Larsen A.K., Gerwien J., Christensen S., Cerami A., et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab 27 3 (2006) 552-563
93. Coleman T.R., Westenfelder C., Togel F.E., Yang Y., Hu Z., Swenson L., et al. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci U S A 103 (2006) 5965-5970